Home Medicine 12 An introduction to quantitative systems pharmacology for chemical engineers
Chapter
Licensed
Unlicensed Requires Authentication

12 An introduction to quantitative systems pharmacology for chemical engineers

  • Roberto A. Abbiati ORCID logo and Cesar Pichardo
Become an author with De Gruyter Brill

Abstract

Quantitative systems pharmacology (QSP) is a discipline that integrates experimental and mathematical modelling practice to perform a variety of analysis in the pharmaceutical research and development space. As the pharma industry strives for leaner product development, reduction of time and costs, and the implementation of the personalized medicine ambition, modeling and simulation approaches are recognized as pivotal components to achieve these goals. Since there are notable similarities between chemical engineering modelling approaches and those of QSP, our aspiration for this chapter is setting the stage for further contribution by engineers in this space. To this end, we provide a concise overview of the various modelling applications currently employed across the pharmaceutical research and development value chain. We then focus on QSP, detailing specific research areas that benefit from its use, the relevant mathematical modelling techniques, and emphasizing its parallels with chemical engineering modelling. Finally, we illustrate two concrete examples of QSP applications in oncological drug development.

Abstract

Quantitative systems pharmacology (QSP) is a discipline that integrates experimental and mathematical modelling practice to perform a variety of analysis in the pharmaceutical research and development space. As the pharma industry strives for leaner product development, reduction of time and costs, and the implementation of the personalized medicine ambition, modeling and simulation approaches are recognized as pivotal components to achieve these goals. Since there are notable similarities between chemical engineering modelling approaches and those of QSP, our aspiration for this chapter is setting the stage for further contribution by engineers in this space. To this end, we provide a concise overview of the various modelling applications currently employed across the pharmaceutical research and development value chain. We then focus on QSP, detailing specific research areas that benefit from its use, the relevant mathematical modelling techniques, and emphasizing its parallels with chemical engineering modelling. Finally, we illustrate two concrete examples of QSP applications in oncological drug development.

Chapters in this book

  1. Preface V
  2. List of contributing authors
  3. Part I Chemical engineering and medicine
  4. 1 A systems engineering approach to medicine 3
  5. Part II Modelling physiology
  6. 2 Computational modelling in liver system and liver disease 21
  7. 3 Inhaled aerosols as carriers of pulmonary medicines and the limitations of in vitroin vivo correlation (IVIVC) methods 49
  8. 4 Modelling drug permeation across the skin: a chemical engineering perspective 73
  9. 5 Chemical engineering contribution to hemodialysis innovation: achieving the wearable artificial kidneys with nanomaterial-based dialysate regeneration 103
  10. Part III Disease and treatment
  11. 6 Precision medicine in hypothyroidism: an engineering approach to individualized levothyroxine dosing 127
  12. 7 Glucose sensors in medicine: overview 167
  13. 8 Macroscopic transport models for drugs and vehicles in cancer tissues 185
  14. 9 Mathematical modelling of hollow-fiber haemodialysis modules 203
  15. 10 Chemical engineering methods in better understanding of blood hydrodynamics in atherosclerosis disease 243
  16. 11 On the development of pharmacokinetic models for the characterisation and diagnosis of von Willebrand disease 263
  17. Part IV Pharmacokinetics and drug delivery
  18. 12 An introduction to quantitative systems pharmacology for chemical engineers 293
  19. 13 A novel strategy for brain cancer treatment through a multiple emulsion system for simultaneous therapeutics delivery 315
  20. 14 Model-based dose selection for gene therapy for haemophilia B 333
  21. 15 Lipid-based nanoparticles for nucleic acids delivery 359
  22. Index
Downloaded on 6.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/9783111394558-012/html
Scroll to top button